Xilio Therapeutics had a revenue of 2.93M in the quarter ending Mar 31, 2025, with 69.95%. This bring the company's revenue in the last twelve months to 9.27M, Decreased 46.19%. In the fiscal year ending Dec 31, 2024, Xilio Therapeutics had annual revenue of 6.34M with Infinity% growth.